Praxis Precision surges on positive ulixacaltamide data for essential tremor, but tolerability limits impact. Explore PRAX's ...

Wall Street boosted the stock’s price targets after the company’s late-stage trial for its essential tremor drug, ...

Success by nearly all measures with Praxis Precision Medicines Inc.’s essential tremor phase III candidate, ulixacaltamide, drove the company’s stock up significantly and provided solid data for an ...

Praxis Precision Medicines said patients with a condition that causes uncontrollable shaking saw improvement using its ...

Oppenheimer analyst Jay Olson recently described Praxis Precision as a leader and "uniquely positioned" in the movement-disorder drug space after the failure of Phase 2 trials from Jazz ...

Patients treated with ulixacaltamide in the parallel-group study (Study 1) showed a mean improvement from baseline in the ...

Essential tremor is a movement disorder marked by involuntary, rhythmic shaking in the hands but sometimes affecting the head, voice and other areas. Its exact cause is still unknown. Recent research ...

Parkinson’s is the fastest growing neurological disease in the world. More than 110,000 Canadians have the disorder and every ...

"It's being open about it [your diagnosis]. Everyone thinks you have Parkinson's and actually, this condition is more common ...

SAN JOSE, Calif. (KGO) -- The Silicon Valley is known for pioneering technology, and now that same spirit of innovation is transforming patient care. Good Samaritan Hospital is the first in the South ...

William “Matt” Howe and Read Montague are senior authors of a study published in Nature Communications that identified a neurochemical signature distinguishing Parkinson’s disease from essential ...

NEW HAVEN, Conn. (WTNH) — In today’s Health headlines, what is essential tremor? A new non-invasive treatment option for essential tremor and what other conditions it may help with too. Dr. Zion Zibly ...